Stocktoria
CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) earns a Piotroski F-score of 2/9 (weak financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend. FY2025 revenue was $1.9B at a -4.4% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Analyst price target
Recent analyst actions
| Date | Firm | Rating |
|---|---|---|
| 2026-06-11 | UBS | Neutral (main) |
| 2026-06-04 | Canaccord Genuity | Buy (main) |
| 2026-03-20 | Canaccord Genuity | Buy (main) |
| 2026-03-05 | Leerink Partners | Market Perform (main) |
| 2026-01-20 | Canaccord Genuity | Buy (main) |
| 2025-11-06 | Canaccord Genuity | Buy (main) |
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Finance, Insurance & Real Estate · percentile among 1129 companies
Percentile vs other Finance, Insurance & Real Estate companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 2/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · distress zone
| Component | Value |
|---|---|
| Working capital / assets | 0.183 |
| Retained earnings / assets | -4.23 |
| EBIT / assets | -0.158 |
| Equity / liabilities | 1.329 |
Sector peers · similar-size Finance, Insurance & Real Estate companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| CLOV | CLOVER HEALTH INVESTMENTS, CORP. /DE | 2/9 | -12.26 | — | +40.3% |
| TRUP | TRUPANION, INC. | 2/9 | 2.14 | — | +11.9% |
| ALHC | Alignment Healthcare, Inc. | 5/9 | -0.35 | — | +46.1% |
| OSCR | Oscar Health, Inc. | 4/9 | -2.18 | — | +27.5% |
| MOH | MOLINA HEALTHCARE, INC. | 4/9 | 3.6 | 25.4 | +11.7% |
| HUM | HUMANA INC | 5/9 | 5.1 | 38.8 | +10.1% |
| CNC | CENTENE CORP | 4/9 | 0.38 | — | +19.4% |
All Finance, Insurance & Real Estate companies →
About CLOVER HEALTH INVESTMENTS, CORP. /DE
Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It also operates Clover Assistant, a software platform for physicians to detect, identify, and manage chronic diseases. The company was founded in 2014 and is based in Wilmington, Delaware.
FAQ
Is CLOV financially healthy?
CLOVER HEALTH INVESTMENTS, CORP. /DE's Piotroski F-score is 2/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.
Does CLOV pay a dividend?
No, CLOVER HEALTH INVESTMENTS, CORP. /DE does not currently pay a dividend.
How profitable is CLOV?
In FY2025, CLOVER HEALTH INVESTMENTS, CORP. /DE had a net margin of -4.4% and a return on equity of -27.7%.
What is the analyst price target for CLOV?
The average Wall-Street price target for CLOVER HEALTH INVESTMENTS, CORP. /DE is $4.15, about 8.6% below the recent price, from 3 analysts.
Is CLOV a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on CLOVER HEALTH INVESTMENTS, CORP. /DE: a Piotroski F-score of 2/9, an Altman Z″ in the distress zone. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.